We are live on ! Find out more
PGNY icon

Progyny

261 hedge funds and large institutions have $3.86B invested in Progyny in 2021 Q4 according to their latest regulatory filings, with 45 funds opening new positions, 110 increasing their positions, 73 reducing their positions, and 42 closing their positions.

New
Increased
Maintained
Reduced
Closed

51% more repeat investments, than reductions

Existing positions increased: 110 | Existing positions reduced: 73

20% more funds holding in top 10

Funds holding in top 10: 56 (+1)

7% more first-time investments, than exits

New positions opened: 45 | Existing positions closed: 42

1% more call options, than puts

Call options by funds: $9.64M | Put options by funds: $9.55M

1% less funds holding

Funds holding: 263261 (-2)

7.31% less ownership

Funds ownership: 92.2%84.89% (-7.3%)

16% less capital invested

Capital invested by funds: $4.62B → $3.86B (-$757M)

Holders
261
Holders Change
-2
Holders Change %
-0.76%
% of All Funds
4.02%
Holding in Top 10
6
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+20%
% of All Funds
0.09%
New
45
Increased
110
Reduced
73
Closed
42
Calls
$9.64M
Puts
$9.55M
Net Calls
+$83K
Net Calls Change
-$11.3M
Name Holding Trade Value Shares
Change
Change in
Stake
TGA
1
TPG GP A
Texas
$504M +$560M +10,000,000 New
BlackRock
2
BlackRock
New York
$399M +$7.62M +136,122 +2%
Macquarie Group
3
Macquarie Group
Australia
$376M +$30.9M +551,544 +8%
Vanguard Group
4
Vanguard Group
Pennsylvania
$326M +$5.94M +106,129 +2%
FAM
5
Fred Alger Management
New York
$230M +$7.86M +140,496 +3%
ClearBridge Investments
6
ClearBridge Investments
New York
$158M +$2.45M +43,725 +1%
American Century Companies
7
American Century Companies
Missouri
$117M +$104M +1,865,151 +407%
Fidelity Investments
8
Fidelity Investments
Massachusetts
$114M +$173K +3,096 +0.1%
State Street
9
State Street
Massachusetts
$100M +$2.68M +47,910 +2%
JP Morgan Chase
10
JP Morgan Chase
New York
$94.5M -$22M -393,411 -17%
Jennison Associates
11
Jennison Associates
New York
$87.8M +$6.35M +113,521 +7%
Geode Capital Management
12
Geode Capital Management
Massachusetts
$59.9M +$3.06M +54,626 +5%
VOYA Investment Management
13
VOYA Investment Management
Georgia
$54.9M -$39.7M -708,374 -39%
Thrivent Financial for Lutherans
14
Thrivent Financial for Lutherans
Minnesota
$54.2M +$20.3M +361,964 +51%
Northern Trust
15
Northern Trust
Illinois
$48.3M +$3.6M +64,250 +7%
BAMCO Inc
16
BAMCO Inc
New York
$44M +$2.04M +36,510 +4%
GKIM
17
GW&K Investment Management
Massachusetts
$42.5M -$449K -8,017 -0.9%
Bank of America
18
Bank of America
North Carolina
$41.3M -$117K -2,082 -0.3%
RP
19
Riverbridge Partners
Minnesota
$40.9M +$45.5M +812,333 New
EAM
20
Eagle Asset Management
Florida
$39.5M -$411K -7,339 -0.9%
WI
21
Wafra Inc
New York
$38.4M +$25.1M +448,820 +143%
Swedbank
22
Swedbank
Sweden
$36.4M +$20.7M +370,000 +109%
Bank of New York Mellon
23
Bank of New York Mellon
New York
$33.4M +$1.76M +31,479 +5%
Dimensional Fund Advisors
24
Dimensional Fund Advisors
Texas
$32.7M +$1.74M +31,102 +5%
PAMS
25
Pictet Asset Management (Switzerland)
Switzerland
$28.1M +$10.4M +186,195 +50%

PGNY Hedge Fund Activity: Q4 2021 in Review

261 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in Progyny (PGNY) for Q4 2021, worth a combined $3.86B — down 16% from $4.62B a quarter earlier.

Buyers outnumbered sellers: 45 funds opened new PGNY positions and 42 closed out — a net gain of 3 holders — while 110 added to existing stakes and 73 trimmed.

The largest buyer was American Century Companies, adding an estimated $104M. The largest seller was OrbiMed, exiting entirely with an estimated $71.1M sold.

  • 261 institutional investors held Progyny (PGNY) as of Q4 2021, down from 263 in Q3 2021.
  • Funds reported $3.86B of Progyny stock for Q4 2021, down 16% quarter-over-quarter.
  • 45 funds opened new Progyny positions in Q4 2021 and 42 closed out, a net change of +3 holders.
  • The largest Progyny buyer in Q4 2021 was American Century Companies, an estimated $104M added.
  • The largest Progyny seller in Q4 2021 was OrbiMed, an estimated $71.1M sold.

Based on aggregated 13F filings for Q4 2021.